$14.31
+0.03 (+0.21%)
Open$14.30
Previous Close$14.28
Day High$14.56
Day Low$14.25
52W High$20.30
52W Low$13.54
Volume—
Avg Volume59.0K
Market Cap183.44M
P/E Ratio—
EPS$-2.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
12 analysts
Price Target
+172.1% upside
Current
$14.31
$14.31
Target
$38.94
$38.94
$25.16
$38.94 avg
$46.24
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.11M | 22.17M | 84.88M |
| Net Income | -26,906,522 | -28,099,175 | 12.73M |
| Profit Margin | -140.8% | -133.8% | 15.0% |
| EBITDA | -27,207,762 | -29,992,311 | 16.15M |
| Free Cash Flow | — | — | 13.25M |
| Rev Growth | -13.8% | -13.8% | +19.4% |
| Debt/Equity | 0.20 | 0.20 | 1.84 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |